Americans are particularly concerned with avoiding animal products. Indeed, a recent study published in the Postgraduate ...
Huahei Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus (HDV), ...
Boehringer Ingelheim has added another drug to its immunology pipeline, licensing an inflammatory bowel disease (IBD) ...
The phase 2 trial of CT-388, a once-weekly subcutaneous injection acquired as part of its $2.7 billion takeover of Carmot ...
The UK has lost its measles elimination status, according to the World Health Organization (WHO), after recording 2,911 ...
In this second of three articles on The Sunday Times top 100 tech companies list, pharmaphorum is focusing on the first nine ...
At the JP Morgan Healthcare conference this year, a lot of the discourse around AI drug discovery focused on making the leap ...
Glimmers of a resurgence in biotech IPO activity in 2026 have continued with the news that two more companies – Belgium's AgomAb Therapeutics and SpyGlass Pharma of the US – are sizing up investor ...
Reports that Eli Lilly was eyeing a takeover of Ventyx Biosciences have been confirmed, suggesting 2026 could follow the bumper pharma M&A trend that started last year. A report in the Wall Street ...
In the evolving landscape of healthcare professional (HCP) engagement, face-to-face interactions remain a cornerstone. They ...
A hole has been blown in Bausch Health's late-stage pipeline, after a follow-up to its top-selling drug product Xifaxan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results